Growth Adaptation to Methotrexate of HT-29 Human Colon Carcinoma Cells Is Associated with Their Ability to Differentiate into Columnar Absorptive and Mucus-secreting Cells

Cancer Research

Volumn 50, Issue 19, 1990, Pages 6334-6343

  Lesuffleur, Thécla ^a   Barbat, Alain ^a   Dussaulx, Elisabeth ^a   Zweibaum, Alain ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; COLON CARCINOMA; CYTOCHEMISTRY; CYTOLOGY; DRUG RESISTANCE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULTRASTRUCTURE;

CARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HUMAN; METHOTREXATE; MICROSCOPY, ELECTRON; MUCINS; MUCUS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025144305     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Imai, H., and Stein, A. A. Ultrastructure of adenocarcinoma of the colon. Gastroenterology, 44:410–418, 1963.
2. Cardoso, J. M. J., Diener, K. A., Alvarez, E. E., and Maldonado, E. M. Electronic microscopy of adenocarcinoma of the colon. Am. J. Proct., 22: 301–307, 1971.
3. Hickey, W. F., and Seiler, M. W. Ultrastructural markers of colonic adenocarcinoma. Cancer (Phila.), 47:140–145, 1981.
4. Czernichow, B., Simon-Assmann, P., Kedinger, M., Arnold, C., Parache, M., Marescaux, J., Zweibaum, A., and Haffen, K. Sucrase-isomaltase expression and enterocytic ultrastructure of human colorectal tumors. Int. J. Cancer, 4: 238–244, 1989.
5. Seiler, M. W., Reilova-Velez, J., Hickey, W. F., and Bono, L. Ultrastructural markers of large bowel cancer. In: S. R. Wolman and A. J. Mastromarino (eds.), Progress in Cancer Research and Therapy, Vol. 29, pp. 51–65. New York: Raven Press, 1984.
6. Rousset, M., Dussaulx, E., Chevalier, G., and Zweibaum, A. Expression phenotypique des antigenes coliques polymorphes (WZ) dan les adenocarci-nomes du colon humain. C. R. Acad. Sci. (Paris), Serie D, 286: 659–662, 1978.
7. Bara, J., Loisillier, F., and Burtin, P. Antigens of gastric and intestinal mucus cells in human colonic tumours. Br. J. Cancer, 41: 209–221, 1980.
8. Bara, J., Gautier, R., Daher, N., Zaghouani, H., and Decaens, C. Monoclonal antibodies against oncofetal mucin MI antigens associated with precancerous colonic mucosae. Cancer Res., 46: 3983–3989, 1986.
9. Brattain, M. G., Levine, A. E., Chakrabarty, S., Yeoman, I. C., Willson, J. K. V., and Long, B. H. Heterogeneity of human colon carcinoma. Cancer Metastasis Rev., 3:177–191, 1984.
10. Wiggers, T., Arends, J. W., Verstijnen, C., Moerkerk, P. M., and Bosman, F. T. Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue. Br. J. Cancer, 54:409–414, 1986.
11. Moll, R., Robine, S., Dudouet, B., and Louvard, D. Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch. B, 54: 155–169, 1987.
12. Kenny, A. J., and Maroux, S. Topology of microvillar membrane hydrolases of kidney and intestine. Physiol. Rev., 62:91–128, 1982.
13. Lacroix, B., Kedinger, M., Simon-Assmann, P., Rousset, M., Zweibaum, A., and Haffen, K. Developmental pattern of brush border enzymes in the human fetal colon. Correlation with some morphogenetic events. Early Hum. Dev., 9:95–103, 1984.
14. Zweibaum, A., Hauri, H. P., Sterchi, E., Chantret, I., Haffen, K., Bamat, J., and Sordat, B. Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and fetal colons. Int. J. Cancer, 34: 591–598, 1984.
15. Richman, P. I., and Bodmer, W. F. Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization. Int. J. Cancer, 39:317–328, 1987.
16. Robine, S., Huet, C., Moll, R., Sahuquillo-Merino, C., Coudrier, E., Zweibaum, A., and Louvard, D. Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc. Natl. Acad. Sci. USA, 82:8488–8492, 1985.
17. Hauri, H. P., Sterchi, E. E., Bienz, D., Fransen, J., and Marxer, A. Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J. Cell Biol., 707;838–851, 1985.
18. Pinto, M., Appay, M. D., Simon-Assmann, P., Chevalier, G., Dracopoli, N., Fogh, J., and Zweibaum, A. Enterocytic differentiation of cultured human colon cancer cells by replacement of glucose by galactose in the medium. Biol. Cell, 44: 193–196, 1982.
19. Pinto, M., Robine-Leon, S., Appay, M. D., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Haffen, K., Fogh, J., and Zweibaum, A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell, 47:323–330, 1983.
20. Chantret, I., Barbat, A., Dussaulx, E., Brattain, M. G., and Zweibaum, A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res., 48: 1936–1942, 1988.
21. Huet, C., Sahuquillo-Merino, C., Coudrier, E., and Louvard, D. Absorptive and mucus secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J. Cell Biol., 105:345–358, 1987.
22. Augeron, C., and Laboisse, C. L. Emergence of permanently differentiated cell clones in a human colonic cell line in culture after treatment with sodium butyrate. Cancer Res., 44: 3961–3969, 1984.
23. Kuan, S. F., Byrd, J. C., Basbaum, C. B., and Kim, Y. S. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res., 47: 5715–5724, 1987.
24. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells “in Vitro” pp. 115–141. New York: Plenum Publishing Corp., 1975.
25. Zweibaum, A., Triadou, N., Kedinger, M., Augeron, C., Robine-Leon, S., Pinto, M., Rousset, M., and Haffen, K. Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. Int. J. Cancer, 32: 407–412, 1983.
26. Zweibaum, A., Pinto, M., Chevalier, G., Dussaulx, E., Triadou, N., Lacroix, B., Haffen, K., Brun, J. L., and Rousset, M. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J. Cell. Physiol., 122: 21–29, 1985.
27. Trugnan, G., Rousset, M., Chantret, I., Barbat, A., and Zweibaum, A. The posttranslational processing of sucrase-isomaltase in HT-29 cells is a function of their state of enterocytic differentiation. J. Cell. Biol., 104: 1199–1205, 1987.
28. Viallard, V., Denis, C., Trocheris, C., and Murat, J. C. Effect of glutamine deprivation and glutamate metabolism or ammonium chloride addition on growth rate, metabolism and differentiation of human colon cancer cell line HT-29. Int. J. Biochem., 18:263–270, 1986.
29. Wice, B. M., Trugnan, G., Pinto, M., Rousset, M., Chevalier, G., Dussaulx, E., Lacroix, B., and Zweibaum, A. The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. J. Biol. Chem., 260:139–146, 1985.
30. Jolivet, J., Cowan, K. H., Curt, G. A., Clendeninn, N. J., and Chabner, B. A. The pharmacology and clinical use of methotrexate. N. Engl. J. Med., 309:1094–1104, 1983.
31. Olsson, N. O., Leclerc, A., Jeannin, J. F., and Martin, F. A simple photometric microassay for the quantitative evaluation of macrophage-mediated cytoxicity on adherent cancer cells. Ann. Immunol. (Inst. Pasteur), 133:245–254, 1982.
32. Zweibaum, A., Oriol, R., Dausset, J., Marcelli-Barge, A., Ropartz, C., and Lanset, S. Definition in man of a polymorphic system of the normal colonic secretions. Tissue Antigens, 6:121–128, 1975.
33. Oriol, R., Rousset, M., Zweibaum, A., Dalix, A. M., Chevalier, G., Dussaulx, E., and Strecker, G. Radioimmunoassay of the WZ polymorphic antigens of normal human colon and their relationship with ABH antigenic determinants. Immunology, 32:131–137, 1977.
34. Zweibaum, A., and Bouhou, E. Studies on digestive groups. I. The A alloan-tigen-alloantibody system in rabbits. Transplantation, 75; 291–293, 1973.
35. Hamada, H., and Tsuruo, T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 83:7785–7789, 1986.
36. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
37. Rousset, M., Paris, H., Chevalier, G., Terrain, B., Murat, J. C., and Zweibaum, A. Growth related enzymatic control of glycogen metabolism in cultured human tumor cells. Cancer Res., 44:154–160, 1984.
38. Rousset, M., Dussaulx, E., Chevalier, G., and Zweibaum, A. Growth-related glycogen levels of human intestine carcinoma cell lines grown in vitro and in vivo in nude mice. J. Natl. Cancer Inst., 65:885–889, 1980.
39. Chung, Y. S., Song, I. S., Erickson, R. H., Sleisenger, M. H., and Kim, Y. S. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res., 45:2976–2982, 1983.
40. Herz, F., and Halwer, M. Preferential alkaline phosphatase isoenzyme induction by sodium butyrate. Biochim. Biophys. Acta, 762: 289–294, 1983.
41. Kim, Y. S., Tsao, D., Siddiqui, B., Whitehead, J. S., Arnstein, P., Bennett, J., and Hicks, J. Effects of sodium butyrate and dimethyl sulfoxide on biochemical properties of human colon cancer cells. Cancer (Phila.), 45: 1185–1192, 1980.
42. Morita, A., Tsao, D., and Kim, Y. S. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line. Cancer Res., 42: 4540–4545, 1982.
43. Dexter, D. L., Barbosa, J. A., and Calabresi, P. JVVV-Dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res., 39:1020–1025, 1979.
44. Dexter, D. L., Crabtree, G. W., Stoeckler, J. D., Savarese, T. M., Ghoda, L. Y., Rogler-Brown, T. L., Parks, R. E., Jr., and Calabresi, F. N,N-Dimethyl-formamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. Cancer Res., 47: 808–812, 1981.
45. Tsao, D., Morita, A., Bella, A., Jr., Luu, P., and Kim, Y. S. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenoma cells. Cancer Res., 42: 1052–1058, 1982.
46. Chakrabarty, S., Tobon, A., Varani, J., and Brattain, M. G. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/ expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor 01. Cancer Res., 48:4059–4064, 1988.
47. Schroy, P., Rifkin, J., Coffey, R. J., Winawer, S., and Friedman, E. Role of transforming growth factor 0–1, in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res., 50: 261–265, 1990.
48. Bodner, A. J., Ting, R. C., and Gallo, R. C. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl. Cancer Inst., 67: 1025–1030, 1981.
49. Ogier-Denis, E., Bauvy, C., Aubery, M., Codogno, P., Sapin, C., Rousset, M., Zweibaum, A., and Trugnan, G. The processing of asparagine-linked oligosaccharides is an early biochemical marker of the enterocytic differen- tiation of HT-29 cells. J. Cell. Biochem., 40:11–23, 1989.
50. Zweibaum, A., Trugnan, G., and Rousset, M. Transcriptional and posttrans-lational control of the expression of sucrase-isomaltase in enterocyte like differentiated cell lines: role of glucose. In: M. J. Lentze and E. E. Sterchi (eds.), Mammalian Brush Border Membrane Proteins, pp. 63–69. Stuttgart: Georg Thieme Verlag, 1988.
51. Chantret, I., Trugnan, G., Dussaulx, E., Zweibaum, A., and Rousset, M. Monensin inhibits the expression of sucrase-isomaltase in Caco-2 cells at the mRNA level. FEBS Lett., 235:125–128, 1988.
52. Rousset, M., Chantret, I., Darmoul, D., Trugnan, G., Sapin, C., Green, F., Swallow, D., and Zweibaum, A. Reversible forskolin-induced impairment of sucrase-isomaltase mRNA levels, biosynthesis, and transport to the brush border membrane in Caco-2 cells. J. Cell. Physiol., 141:627–635, 1989.
53. Denis, C., Mils, V., Murat, J. C., Rousset, M. Pinto, M., Trocheris, V., Zweibaum, A., and Paris, H. Evidence for development of gluconeogenesis in the HT-29 human colon adenocarcinoma cell-line grown in a glucose-free medium. I. R. C. S. Med. Sci., 13:898–899, 1985.
54. Schimke, R. T. Gene amplification in cultured animal cells. Cell, 37: 705–713, 1984.
55. Gottesman, M. M., and Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem., 263:12163–12166, 1988.
56. Mickley, L. A., Bates, S. E., Richert, N. D., Currier, J., Tanaka, S., Foss, F., Rosen, N., and Fojo, A. T. Modulation of the expression of multidrug resistance gene (mdr- 1/P-glycoprotein) by differentiating agents. J. Biol. Chem., 264:18031–18040, 1989.
57. Riordaan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., and Ling, V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (Lond.), 316: 817–819, 1985.